MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
831.77%
Quick Ratio
796.01%
Cash Ratio
335.75%
Debt to Asset Ratio
9.43%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Short-term investments
Long-term investments
Others
Liabilities Breakdown
Additional paid-in capital
Retained earnings
Accrued rebates
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
427,740
501,313
496,304
392,604
Short-term investments
417,891
322,092
331,487
338,465
Accounts receivable, net
138,662
127,022
127,425
129,633
Inventory
45,556
42,646
40,475
37,632
Prepaid taxes
15,308
10,642
14,006
10,103
Prepaid expenses and other current assets
14,491
16,026
14,905
17,213
Total current assets
1,059,648
1,019,741
1,024,602
925,650
Property and equipment, net
153,775
153,582
150,776
148,871
Long-term investments
257,291
193,485
128,066
133,113
Right-of-use assets
6,826
7,035
7,239
7,447
Deferred tax asset, net of valuation allowance
22,824
22,824
22,824
24,680
Other non-current assets
284
300
287
333
Total assets
1,500,648
1,396,967
1,333,794
1,240,094
Accounts payable
6,544
4,089
3,238
2,097
Current portion of lease liability
1,808
1,800
1,771
1,698
Accrued rebates
83,480
70,717
58,181
55,769
Accrued expenses and other current liabilities
35,565
31,196
39,752
31,704
Total current liabilities
127,397
107,802
102,942
91,268
Lease liability
7,045
7,312
7,568
7,813
Other long-term liabilities
7,080
5,124
3,724
3,137
Total liabilities
141,522
120,238
114,234
102,218
Additional paid-in capital
1,228,598
1,198,257
1,194,261
1,164,013
Accumulated other comprehensive (loss) gain
-4,335
-1,623
1,136
1,100
Retained earnings
134,863
80,095
24,163
-27,237
Total stockholders equity
1,359,126
1,276,729
1,219,560
1,137,876
Total liabilities and stockholders equity
1,500,648
1,396,967
1,333,794
1,240,094
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$427,740K
(20.89%↑ Y/Y)
Short-term investments
$417,891K
(27.34%↑ Y/Y)
Accounts receivable, net
$138,662K
(24.43%↑ Y/Y)
Inventory
$45,556K
(46.76%↑ Y/Y)
Prepaid taxes
$15,308K
Prepaid expenses and
other current assets
$14,491K
(-14.16%↓ Y/Y)
Total current assets
$1,059,648K
(25.95%↑ Y/Y)
Long-term investments
$257,291K
(85.36%↑ Y/Y)
Property and equipment,
net
$153,775K
(2.25%↑ Y/Y)
Deferred tax asset, net of
valuation allowance
$22,824K
Right-of-use assets
$6,826K
(-10.83%↓ Y/Y)
Other non-current
assets
$284K
(44.16%↑ Y/Y)
Total assets
$1,500,648K
(31.82%↑ Y/Y)
Total liabilities and
stockholders equity
$1,500,648K
(31.82%↑ Y/Y)
Total stockholders
equity
$1,359,126K
(30.60%↑ Y/Y)
Total liabilities
$141,522K
(44.78%↑ Y/Y)
Accumulated other
comprehensive (loss) gain
-$4,335K
(-474.68%↓ Y/Y)
Additional paid-in capital
$1,228,598K
(7.20%↑ Y/Y)
Retained earnings
$134,863K
(226.51%↑ Y/Y)
Total current
liabilities
$127,397K
(46.61%↑ Y/Y)
Other long-term
liabilities
$7,080K
(154.04%↑ Y/Y)
Lease liability
$7,045K
(-12.64%↓ Y/Y)
Accrued rebates
$83,480K
(61.66%↑ Y/Y)
Accrued expenses and
other current...
$35,565K
(34.12%↑ Y/Y)
Accounts payable
$6,544K
(-8.14%↓ Y/Y)
Current portion of lease
liability
$1,808K
(11.81%↑ Y/Y)
Buy us a coffee
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS)